본문 바로가기
KERD
논문KCI 등재

Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study

2

조회

0

다운로드

4

인용

0

참고문헌

키워드

초록

Objective: We aimed to investigate the longitudinal trends in prevalence of hypertriglyceridemia in Korean adults and hypertriglyceridemia-associated lifestyle habits, socioeconomic factors and comorbidities. Methods: Data from the 2007–2020 Korea National Health and Nutrition Examination Survey (KNHANES) were used in this study. Two cutoff values (≥150 mg/dL and ≥200 mg/dL) for fasting serum triglyceride levels were used to estimate the age- and sex-specific prevalence of hypertriglyceridemia. Use of lipid-lowering medications, lifestyle factors such as smoking, alcohol consumption, and regular exercise, socioeconomic variables such as educational attainment and household income, and comorbidities such as obesity, abdominal obesity, hypertension, and diabetes mellitus were also investigated. Results: The prevalence of hypertriglyceridemia among Koreans based on KNHANES 2007–2020 was 29.6% at ≥150 mg/dL and 16.1% at ≥200 mg/dL. While the rate of using lipid-lowering medications increased steadily from 2007 to 2020, changes in annual prevalence of hypertriglyceridemia were subtle. The prevalence of hypertriglyceridemia in men peaked in middle age (47.7% and 30.0% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 40s), but its prevalence in women increased throughout their lifetime (32.6% and 14.7% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 70s). Smoking and high-risk drinking exacerbated peak prevalence in both sexes. Young adults with any comorbidities had prominently increased prevalence of hypertriglyceridemia. The lowest levels of education and income were both associated with the higher prevalence of hypertriglyceridemia in both sexes. Conclusion: It is important to understand the age- and sex-specific epidemiology of hypertriglyceridemia to establish its appropriate management plans.

Abstract

Objective: We aimed to investigate the longitudinal trends in prevalence of hypertriglyceridemia in Korean adults and hypertriglyceridemia-associated lifestyle habits, socioeconomic factors and comorbidities. Methods: Data from the 2007–2020 Korea National Health and Nutrition Examination Survey (KNHANES) were used in this study. Two cutoff values (≥150 mg/dL and ≥200 mg/dL) for fasting serum triglyceride levels were used to estimate the age- and sex-specific prevalence of hypertriglyceridemia. Use of lipid-lowering medications, lifestyle factors such as smoking, alcohol consumption, and regular exercise, socioeconomic variables such as educational attainment and household income, and comorbidities such as obesity, abdominal obesity, hypertension, and diabetes mellitus were also investigated. Results: The prevalence of hypertriglyceridemia among Koreans based on KNHANES 2007–2020 was 29.6% at ≥150 mg/dL and 16.1% at ≥200 mg/dL. While the rate of using lipid-lowering medications increased steadily from 2007 to 2020, changes in annual prevalence of hypertriglyceridemia were subtle. The prevalence of hypertriglyceridemia in men peaked in middle age (47.7% and 30.0% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 40s), but its prevalence in women increased throughout their lifetime (32.6% and 14.7% for ≥150 mg/dL and ≥200 mg/dL, respectively, in their 70s). Smoking and high-risk drinking exacerbated peak prevalence in both sexes. Young adults with any comorbidities had prominently increased prevalence of hypertriglyceridemia. The lowest levels of education and income were both associated with the higher prevalence of hypertriglyceridemia in both sexes. Conclusion: It is important to understand the age- and sex-specific epidemiology of hypertriglyceridemia to establish its appropriate management plans.

참고문헌 (44)

  1. GBD Tuberculosis Collaborators, "The global burden of tuberculosis : results from the Global Burden of Disease Study 2015", Lancet Infect Dis, 18, pp.261~284 (2018)
  2. Banach M, "Statin non-adherence and residual cardiovascular risk : there is need for substantial improvement", Int J Cardiol, 225, pp.184~196 (2016)
  3. Tenenbaum A, "Hypertriglyceridemia : a too long unfairly neglected major cardiovascular risk factor", Cardiovasc Diabetol, 13, pp.159~ (2014)
  4. Kim NH, "Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study", BMJ, 366, pp.l5125~ (2019)
  5. Sone H, "Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes : subanalysis of the Japan Diabetes Complications Study(JDCS)", J Clin Endocrinol Metab, 96, pp.3448~3456 (2011)
  6. Patel A, "Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region", Circulation, 110, pp.2678~2686 (2004)
  7. Mensah GA, "Obesity, metabolic syndrome, and type 2 diabetes : emerging epidemics and their cardiovascular implications", Cardiol Clin, 22, pp.485~504 (2004)
  8. 조소미, "Dyslipidemia Fact Sheets in Korea 2020: an Analysis of Nationwide Population-based Data", 지질·동맥경화학회지, 10(2), pp.202~209 (2021), 한국지질동맥경화학회[DOI]
  9. Lee KH, "Contribution of APOA5-1131C allele to the increased susceptibility of diabetes mellitus in association with higher triglyceride in Korean women", Metabolism, 59, pp.1583~1590 (2010)
  10. Park SH, "Dietary carbohydrate intake is associated with cardiovascular disease risk in Korean : analysis of the third Korea National Health and Nutrition Examination Survey(KNHANES III)", Int J Cardiol, 139, pp.234~240 (2010)
  11. Korean Diabetes Association, "Diabetes fact sheet 2020", Korean Diabetes Association, ~ (2020)
  12. Huh JH, "Metabolic syndrome fact sheet 2021 : executive report", Cardiometab Syndr J, 1, pp.125~134 (2021)
  13. 남가은, "Obesity Fact Sheet in Korea, 2020: Prevalence of Obesity by Obesity Class from 2009 to 2018", Journal of Obesity & Metabolic Syndrome, 30(2), pp.141~148 (2021), 대한비만학회[DOI]
  14. National Cholesterol Education Program(NCEP)Expert Panel on Detection, "Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)", Circulation, 106, pp.3143~3421 (2002)
  15. 이은정, "2018 Guidelines for the Management of Dyslipidemia in Korea", 지질·동맥경화학회지, 8(2), pp.78~131 (2019), 한국지질동맥경화학회[DOI]
  16. WHO Expert Consultation, "Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies", Lancet, 363, pp.157~163 (2004)
  17. 김보연, "2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea", Journal of Obesity & Metabolic Syndrome, 30(2), pp.81~92 (2021), 대한비만학회[DOI]
  18. The national health and nutrition survey in Japan, "Ministry of Health, Labour and Welfare (JP)", Ministry of Health, Labour and Welfare, ~ (2015)
  19. Bureau of Health Promotion, Department of Health (TW), "Taiwan Survey on Hypertension, Hyperglycemia, and Hyperlipidemia (TwSHHH)" (2002), Department of Health
  20. Cai L, "Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China", J Atheroscler Thromb, 19, pp.159~168 (2012)
  21. Guerrero AE, "2015 clinical practice guidelines for the management of dyslipidemia in the Philippines-executive summary", ASEAN Heart J, 24, pp.7~ (2016)
  22. Aekplakorn W, "Prevalence of dyslipidemia and management in the Thai population, National Health Examination Survey IV", J Lipids, 2014, pp.249584~ (2014)
  23. Qiao Q, "Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women", Diabetologia, 49, pp.2837~2846 (2006)
  24. Fan W, "Prevalence of US adults with triglycerides ≥ 150 mg", dL : NHANES 2007-2014, 2020, pp.9, 207~213
  25. Iso H, "Changes in coronary heart disease risk among Japanese", Circulation, 118, pp.2725~2729 (2008)
  26. Gupta R, "Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population", Lipids Health Dis, 7, pp.40~ (2008)
  27. Schreiner PJ, "Twenty-five year secular trends in lipids and modifiable risk factors in a population-based biracial cohort : the Coronary Artery Risk Development in Young Adults(CARDIA)study, 1985-2011", J Am Heart Assoc, 5, pp.e003384~ (2016)
  28. Chang Y, "Long-term trends in smoking prevalence and its socioeconomic inequalities in Korea, 1992-2016", Int J Equity Health, 18, pp.148~ (2019)
  29. Li Z, "Distribution of lipid levels and prevalence of hyperlipidemia : data from the NHANES 2007-2018", Lipids Health Dis, 21, pp.111~ (2022)
  30. Grønbaek M, "The positive and negative health effects of alcohol-and the public health implications", J Intern Med, 265, pp.407~420 (2009)
  31. Luo WS, "Interaction of tobacco smoking and alcohol consumption with obesity on cardiovascular disease in a Chinese cohort", Coron Artery Dis, 31, pp.372~377 (2020)
  32. Heidari R, "Metabolic syndrome in menopausal transition : Isfahan Healthy Heart Program, a population based study", Diabetol Metab Syndr, 2, pp.59~ (2010)
  33. Nelson MC, "Emerging adulthood and college-aged youth : an overlooked age for weight-related behavior change", Obesity(Silver Spring), 16, pp.2205~2211 (2008)
  34. Bouchard C, "Adverse metabolic response to regular exercise : is it a rare or common occurrence?", PLoS One, 7, pp.e37887~ (2012)
  35. Stanton KM, "Moderate-and high-intensity exercise improves lipoprotein profile and cholesterol efflux capacity in healthy young men", J Am Heart Assoc, 11, pp.e023386~ (2022)
  36. Thompson PD, "Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease : a statement from the Council on Clinical Cardiology(Subcommittee on Exercise, Rehabilitation, and Prevention)and the Council on Nutrition, Physical", Circulation, 107, pp.3109~3116 (2003)
  37. Fiuza-Luces C, "Exercise benefits in cardiovascular disease : beyond attenuation of traditional risk factors", Nat Rev Cardiol, 15, pp.731~743 (2018)
  38. Gombojav B, "The Healthy Twin Study, Korea updates : resources for omics and genome epidemiology studies", Twin Res Hum Genet, 16, pp.241~245 (2013)
  39. Backholer K, "Sex differences in the relationship between socioeconomic status and cardiovascular disease : a systematic review and meta-analysis", J Epidemiol Community Health, 71, pp.550~557 (2017)
  40. Yoon YS, "Socioeconomic status in relation to obesity and abdominal obesity in Korean adults : a focus on sex differences", Obesity(Silver Spring), 14, pp.909~919 (2006)
  41. Park SJ, "Sex differences in the relationship between socioeconomic status and metabolic syndrome : the Korean National Health and Nutrition Examination Survey", Diabetes Res Clin Pract, 96, pp.400~406 (2012)
  42. Subramanian S, "Hypertriglyceridemia secondary to obesity and diabetes", Biochim Biophys Acta, 1821, pp.819~825 (2012)
  43. De Man FH, "Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus : post-prandial metabolism and relation to premature atherosclerosis", Eur J Clin Invest, 26, pp.89~108 (1996)
  44. Blüher M, "Obesity : global epidemiology and pathogenesis", Nat Rev Endocrinol, 15, pp.288~298 (2019)

관련 논문AI추천

이 간행물의 다른 논문 (9건)